NCT06619340
EXPAREL IPSA Block in Knee Arthroplasty
Enrolling by Invitation
PHASE4Ages 18+InterventionalTreatmentCampbell ClinicInvestigator-initiated
~10 participants
Updated 2024-10-01 on ClinicalTrials.gov
What's tested:Exparel
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Pain Assessment - 24hr recall
Measured over Study Enrollment, Post-operative Day 1, Post-operative Day 2, Post-operative Day 3, Post-operative Day 14, Post-operative Day 42
+1 more outcome measured
Conditions
NCT06619340
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Campbell Clinic
Germantown, Tennesseeno site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- William Mihalko, MD, PhD · PRINCIPAL_INVESTIGATOR · Campbell Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Pain Assessment - 24hr recallStudy Enrollment, Post-operative Day 1, Post-operative Day 2, Post-operative Day 3, Post-operative Day 14, Post-operative Day 42
On a 0-10 scale, record worst pain in the last 24 hours and average pain in the last 24 hours, with 0 being no pain at all and 10 being the worst pain possible.
- Pain Assessment - current painStudy Enrollment, On Admission to Surgery, on Post Anesthesia Care Unit (PACU) Admission, every 15 minutes from PACU admission to discharge home, 12 hours after surgery, Post-operative Day (POD) 1, POD 2, POD 3, POD 14, POD 42
On a 0-10 scale, record current pain level, with 0 being no pain at all and 10 being the worst pain possible.